Zeolitic Imidazolate Framework-8 (ZIF-8), for the first time for ZIFs, exhibits a remarkable capacity for the anticancer drug 5-fluorouracil (5-FU), around 660 mg of 5-FU/g of ZIF-8, and presents a pH-triggered controlled drug release property. These prove ZIF-8 to be a valuable candidate for delivery of anticancer agents and reveal its potential applications in the treatment of cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c2dt30357d | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!